Search research articles
Contact Us
Filters
Showing results (171-180 of 193) with videos related to
Page
of 20
Sort By:
Journal of Geriatric Oncology
|
September 6, 2024
Evaluating concordance between International Myeloma Working Group (IMWG) frailty score and simplified frailty scale among older adults with multiple myeloma
Andrew Gahagan, Supriya Maheshwari, Sunil Rangarajan, et al.
Blood Advances
|
May 21, 2020
Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States
Amer M Zeidan, Rong Wang, Xiaoyi Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 18, 2015
Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation
Vijaya Raj Bhatt, Vamshi Balasetti, Jagar A Jasem, et al.
Cancer
|
April 5, 2024
Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphoma
Smith Giri, Christian Harmon, Wendy Landier, et al.
Experimental Gerontology
|
April 29, 2023
Associations of interleukin-6 with functional trajectories in older adults with cancer: Findings from the Health, Aging, and Body Composition Study
Kah Poh Loh, William Consagra, Allison Magnuson, et al.
Blood Advances
|
April 21, 2020
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, et al.
British Journal of Haematology
|
February 16, 2026
Validation of the 2025 IMS/IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplant
Priyanka Venkatesh, Gayathri Ravi, Binod Dhakal, et al.
Blood Cancer Journal
|
January 4, 2023
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Hira Mian, Arleigh McCurdy, Smith Giri, et al.
Ejhaem
|
August 21, 2023
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation
Rebecca W Silbermann, Timothy Martin Schmidt, Susan Bal, et al.
Transplantation and Cellular Therapy
|
June 21, 2021
Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Survivor Study Report
Smith Giri, Yanjun Chen, Jessica Wu, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 193) with videos related to
Sort By:
Page
of 20
Journal of Geriatric Oncology
|
September 6, 2024
Evaluating concordance between International Myeloma Working Group (IMWG) frailty score and simplified frailty scale among older adults with multiple myeloma
Andrew Gahagan, Supriya Maheshwari, Sunil Rangarajan, et al.
Blood Advances
|
May 21, 2020
Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States
Amer M Zeidan, Rong Wang, Xiaoyi Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 18, 2015
Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation
Vijaya Raj Bhatt, Vamshi Balasetti, Jagar A Jasem, et al.
Cancer
|
April 5, 2024
Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphoma
Smith Giri, Christian Harmon, Wendy Landier, et al.
Experimental Gerontology
|
April 29, 2023
Associations of interleukin-6 with functional trajectories in older adults with cancer: Findings from the Health, Aging, and Body Composition Study
Kah Poh Loh, William Consagra, Allison Magnuson, et al.
Blood Advances
|
April 21, 2020
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, et al.
British Journal of Haematology
|
February 16, 2026
Validation of the 2025 IMS/IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplant
Priyanka Venkatesh, Gayathri Ravi, Binod Dhakal, et al.
Blood Cancer Journal
|
January 4, 2023
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Hira Mian, Arleigh McCurdy, Smith Giri, et al.
Ejhaem
|
August 21, 2023
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation
Rebecca W Silbermann, Timothy Martin Schmidt, Susan Bal, et al.
Transplantation and Cellular Therapy
|
June 21, 2021
Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Survivor Study Report
Smith Giri, Yanjun Chen, Jessica Wu, et al.
Page
of 20